The HD-domain superfamily of enzymes

HD proteins are omnipresent and belong to a superfamily of metalloenzymes counting presently > 137,000 members with diverse and unknown functions affecting the human health and environment, including HIV-1 immunoresponse, anti-virulence, DNA/RNA unwinding and degradation, and signaling. Whereas their initial functionality was predicted to be solely hydrolytic, novel diiron oxygenases have emerged carrying out chemically difficult small molecule activations. 

These proteins are typified by a helical fold harboring the H…HD…D residue quartet, known to bind a divalent metal ion (most commonly Zn2+). The presence of two additional histidines inbetween the aspartate residues extends their metal binding capacity and supports formation of di- or even tri-nuclear clusters.  Though members of this superfamily were originally annotated as (phospho)hydrolases, less than a decade ago, a diiron HD enzyme involved in the catabolism of inositol associated with type I diabetes mellitus, namely myo-inositol oxygenase (MIOX) was demonstrated to carry out a radically different reaction using molecular oxygen to afford transformation of its substrate. The only recently recognized HD enzyme PhnZ, was also shown to follow the paradigm of MIOX, employing oxygen for the acquisition of phosphate from an organophosphonate by marine microorganisms. Biochemically uncharacterized dinuclear HD domain proteins have been selected as targets for discovering their substrates, identifying key residues that favor hydrolase or oxygenase activity and examining the catalytic potency of the types of metals incorporated. Considering the emergence of MIOX and PhnZ as evolutionary means to carry out reactions affecting the human health and environment, as well as the emergence of hydrolytic HD enzymes orchestrating immunoresponse in eukaryotes and prokaryotes, our work aims to serve as a paradigm for discovering new antiviral (and therapeutic) factors and functions within the largely uncharacterized HD superfamily.